(Q44102755)
Statements
1 reference
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study (English)
1 reference
M Arato
1 reference
R O'Connor
1 reference
H Y Meltzer
1 reference
ZEUS Study Group
1 reference
1 September 2002
1 reference
1 reference
17
1 reference
5
1 reference
207-215
1 reference
Identifiers
1 reference
1 reference